Should Bivalirudin Replace Heparin During Percutaneous Coronary Interventions?
- 19 February 2003
- journal article
- editorial
- Published by American Medical Association (AMA)
- Vol. 289 (7) , 903-5
- https://doi.org/10.1001/jama.289.7.903
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary InterventionJAMA, 2003
- Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trialJournal of the American College of Cardiology, 2003
- Design and analysis of non‐inferiority mortality trials in oncologyStatistics in Medicine, 2002
- ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary articleJournal of the American College of Cardiology, 2002
- Tissue factor – a therapeutic target for thrombotic disordersEmerging Therapeutic Targets, 2002
- Direct Thrombin Inhibitors in Acute Coronary SyndromesCirculation, 2002
- Statistical Methods for Comparison to Placebo in Active-Control TrialsDrug Information Journal, 2001
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeThe Lancet, 1998
- Equivalence TrialsNew England Journal of Medicine, 1997
- A Comparison of Reteplase with Alteplase for Acute Myocardial InfarctionNew England Journal of Medicine, 1997